Latest News of VYNE
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully
By Yahoo! Finance |
1 month ago
Investors are drawn to unprofitable companies due to growth potential. Analyzing VYNE Therapeutics' cash burn and runway, it is crucial to monitor its cash reserves and revenue growth for investment d...
One VYNE Therapeutics Insider Raised Stake By 55% In Previous Year
By Yahoo! Finance |
3 months ago
Insiders at VYNE Therapeutics have been net buyers over the past year, indicating confidence in the company's future. Lead Independent Director Patrick LePore made the biggest insider purchase. While ...